Cover Corona Outbreak Impact: Cancer/Tumor Profiling Market is expected to Boom in Coming Years

Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass. For effective treatment, merely detecting the tumor within the body is not enough; its nature and the exact mutation which caused it also need to be studied.

Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample

Therefore, owing to the increasing number of people suffering from this disease and the high focus on deeply studying its various aspects, in order to device an effective therapy, the cancer/tumor profiling market is growing around the world. Several technologies, including quantitative polymerase chain reaction (QPCR), next-generation sequencing (NGS), in-situ hybridization (ISH), immunohistochemistry (IHC), and microarray, are used to study the tumors. Of these, NGS has been the most widely preferred till now, on account of its ability to quickly detect the sequencing of the deoxyribonucleic acid (DNA) in the genome.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=cancer-profiling-market

Seeing the increasing demand for cancer profiling services, biotech companies have started launching new enabling products. For instance, MDNA Life Sciences Inc. introduced the Prostate Mitomic Test in the U.S. in May 2017. This liquid-biopsy-based test, which is available at the clinical laboratories of Helomics Corp., uses mitochondrial DNA's biological characteristics to study the disease. Similarly, the Dynamic Clinical Health Insight Platform (D-CHIP) launched by Helomics Corp. in April 2017 helps in the in-depth analysis of the proteins, genome, RNA, and DNA of cancer patients.

Therefore, on account of the improvements in diagnosis methods, the demand for cancer/tumor profiling products and services will keep surging.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.